Investor

Some leaders say AI will improve a massively inefficient, overpriced and difficult-to-access healthcare system, while others anticipate AI’s potential for earlier, more accurate diagnosis.

The global data, analytics and AI company will use the Series J funds to invest in new AI products, complete acquisitions and expand its international go-to-market operations.

AI will transform healthcare with advances in multimodal technology, diagnostic imaging and automation, but its success depends on trust and seamless integration into workflows.

Some executives anticipate an acceleration of M&A activity as struggling startups seek exits, while others foresee more funding opportunities for companies with proven value in the sector.

Antoine Robiliard, VP of health solutions at Withings, told MobiHealthNews that 2025 is set to bring growth in at-home care, M&A-driven scalability and a clearer understanding of AI's practical impact on healthcare.

Requests are being taken for multiple awards backing space-based tissue and mechanobiology.

The acquisition bolsters CCC's AI-powered SaaS platform by adding transformative AI capabilities.

Leaders weigh in on the digital health funding environment, women's health investments and how "AI washing" may influence capital raises.

The company touts that it recently surpassed 2.5 million rings sold and has seen its member base and revenue more than double over the past year.

Digital health leaders comment on the year's significant events, including the shuttering of Walmart Health, the CrowdStrike outage, concerns about off-label advertising and more.